This podcast is brought to you by United Imaging, co-chair of the SNMMI Value Initiative Industry Alliance. Hosts Dr. Munir Ghesani, former President of SNMMI, co-Chair of the Mars Shot Research Fund, and Dr. Stephen Lokitz, a NM physicist and Executive Director and Director of Imaging Sciences at the Center for Molecular Imaging and Therapy, or CMIT, discuss nuclear medicine procedures performed and their plans for the future.

This episode is a recorded presentation delivered by Robert Gatenby, MD from the Moffitt Cancer Center during the opening plenary at the SNMMI 2024 Artificial Intelligence Summit, "AI In Action" held Feb 29 - March 1, 2024.  Dr. Gatenby has used evolutionary dynamics models to develop an adaptive therapy approach for the treatment of cancer which he describes during his talk.  Join this podcast and discover an innovative and effective approach to treating cancer – the use of evolutionary biology, mathematical oncology and radiopharmaceutical therapy.  

Drs. Jon McConathy, David A. Wolk, and Illya M. Nasrallah provide an update and information about neuro imaging related to Alzheimer's disease, particularly amyloid and tau imaging.

Dr. Tina Buehner, Dr. Remo George, Jose “Freddy” Gonzalez, and Erika Padilla-Morales discuss the importance of research in advancing nuclear medicine and the impact of research on patient care and the future of molecular imaging.

Dr. Stephen A. Graves and Dr. Andrei Iagaru discuss the opportunities, threats, challenges, trends, and lessons learned regarding radiopharmaceutical therapy with moderator Dr. Phillip J. Koo.

Dr. Jean-Mathieu Beauregard and Dr. Carlos Uribe discuss the present, future, and implications of dosimetry with moderator Dr. John Sunderland.

In part 2 of a conversation with Dr. Stephen Graves and Dr. Benjamin Auer, our two experts continue their discussion on quantitative SPECT, its place in regards to PET, requirement, and current status.

In part 1 of a conversation with Dr. Stephen Graves and Dr. Benjamin Auer, our two experts discuss quantitative SPECT, its place in regards to PET, requirement, and current status.

Umar Mahmood, MD, PhD, and Andrei Iagaru, MD—the inaugural recipient of the Sam Gambhir Trailblazer Award—discuss Dr. Gambhir's life and legacy, including personal and professional recollections. Dr. Iagaru also shares his thoughts on the future of nuclear medicine therapies, what keeps him motivated, and more.

This new SNMMI award was created in memory of Sanjiv 'Sam' Gambhir, MD, PhD, who passed away in July 2020. He was Professor and Chair of Radiology at the Stanford School of Medicine and an internationally recognized pioneer in molecular imaging. The Sam Gambhir Trailblazer Award honors outstanding achievement in excellence in transformative research (either basic science, translational science or clinical science) and exceptional mentorship for mid-career professionals.

This episode features Simon Cherry, PhD, discussing his recent 2022 Annual Meeting Cassen Award Lecture and more in a wide-ranging conversation with SNMMI President, Munir Ghesani, MD.

In his lecture—A Matter of Time—at the SNMMI 2022 Annual Meeting, Cassen Award Winner Simon Cherry, PhD , explored time, and its role in nuclear medicine, from historical developments occurring over decades, to technologies that can detect photons with a precision of tens of picoseconds. Inspired by the groundbreaking ideas of Benedict Cassen and others, Dr. Cherry charted the journey from the past and into the future to create the ultimate imaging devices for studying the body and its many interacting systems

The Benedict Cassen Prize is awarded by the Education and Research Foundation (ERF) for Nuclear Medicine and Molecular Imaging in recognition of outstanding achievement and work leading to a major advance in nuclear medicine science.

Heather Jacene, MD, SNMMI Scientific Program Chair, sits for a conversation with E.G. Elisabeth de Vries, MD, PhD—the SNMMI 2022 Annual Meeting Henry N. Wagner, Jr., MD, Lectureship Speaker—for a preview of her lecture: Seeing the Light with Molecular Imaging for Systemic Cancer Treatment Decisions.